{"name":"Prothya Biosolutions","slug":"prothya-biosolutions","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Cofact","genericName":"Cofact","slug":"cofact","indication":"Other","status":"phase_1"},{"name":"PPSB-SD","genericName":"PPSB-SD","slug":"ppsb-sd","indication":"Other","status":"marketed"},{"name":"human coagulation Factor IX","genericName":"human coagulation Factor IX","slug":"human-coagulation-factor-ix","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Cofact","genericName":"Cofact","slug":"cofact","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"PPSB-SD","genericName":"PPSB-SD","slug":"ppsb-sd","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"human coagulation Factor IX","genericName":"human coagulation Factor IX","slug":"human-coagulation-factor-ix","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOM1VJMFZkUXNXTElEako1UU9ELXZGZ0t3Wk95SEQxTjdJRnNGcldVN3kwck02Z2RsLVVfaE9mY2NMbDd6c29tOWtLR3JwTVFjTGIyUFVSdHZva210c0dtcHRfem53dUZTclplQy0tb2NKOVJ5TnlReG1nWnQxeUNIU19GX1NfRUF1MVpuM2lwWGJxNjd1eHNjVWlvNVA1VUN2M0VnMTl3UmllaVZ3bGJtdGVtUFBYQk9JaFd0QnlFU0p1UXNkX2YyOXE0NFB3eEsyMlVReUFBTE5BSVVaSHhxT3Z1Zw?oc=5","date":"2026-03-13","type":"pipeline","source":"businessfocusmagazine.com","summary":"Accord Healthcare - businessfocusmagazine.com","headline":"Accord Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNWmVGZmdYV3dCeENTaDBVNVNpWExXZFg0LXlIelVPd2c4SFdZaGNrZnNhMWdmdUtSeGlVVmQyeW9LTFlBeEdiME93T3FHUkxzU2FFVFVJSC1GVVVoTlE0T2MxUHhaTmpqWjM3TE43Y2R2N2xUZFltbWNfOXhjb3dfSnI5UkhCU2xEbjlJenVTaVJ1SHl3MktEeVh2U0JEVlJSdmFnZDBUT1pTSnFVcHVQa3hTUFNhM3R6Qmo0Q3FpWnBJUHhGbzYzeGhkelEtd25tMjM2YzVuSnVWM0Q4?oc=5","date":"2026-01-05","type":"pipeline","source":"PR Newswire UK","summary":"Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK - PR Newswire UK","headline":"Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdDlwelJkb0FRZUZXTUY5ZHVfQTBnTkRsSjRNYW91Y3pRYlI5dWIzd29KdFdudVBIWFpvRTNBMDA4aDBhcWI5b3JoUG5OYVBVakgzeEdMNEdOSTBzS0tRT1NqaG9oRWNnVWRQWFFMMWI5NF9qamwxVHpyMU1HX296eDhuLVlrbnFsNm1qc1NvRWNDaG91d0pvalJpWkF1VGpuckZSNk9zRU5ldw?oc=5","date":"2025-12-11","type":"pipeline","source":"The Pharma Letter","summary":"Accord’s success story continues through growth on many fronts - The Pharma Letter","headline":"Accord’s success story continues through growth on many fronts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxONkZ0NUY5SWFVMTBCTlV3TnZRYjRneFlxUC1WNzZybVlub2hzNUNJRUZ4SGVkeVR4WEUwMHJwdlFxeHNfNmVwS0RWdlZIdUVyT1lHZFJZd1hyV19GZ1dWQWJtc2ZQamJUWFU1SmVvZS15YWNQaVE4ZUpGRG9ORmZuOGl3dEk3NzhNdkNrX0IxbmtTbW1xTzdfbGw4alZqbnlETWpPZEl5NVJyYlU4TmhCYjI3SUp5LV95M3hpaklhUW9WSkJBVnJTbF90TTJpUFBMbUluazBhTmo?oc=5","date":"2025-12-02","type":"patent","source":"PR Newswire","summary":"Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health - PR Newswire","headline":"Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNZXJmWHlxQ0dSQUVlVGhMWHlZNGVFNHA1UW1zMzdCS3RsQUxYZ2RobE1IbGZpc3NIaTBJQVlwQThNajl2dk1pb0dkLTdQR3RvTVZ2VGM5clFVSFdkaU1wbFBwRWJzVjAzM1NDZGxLMVFFajJ2YVE1UjBfbVhxNTFEbUpOdEtza3RnbC1xQ2VKVlBhbUpxbGd2RG1fWTdULVV1aVBjYzNnc0loYi0xNzVJME4wbTVqOVpBWEhDZWRvWWdEZDA0WEhucG9yT1pDc2xyaGJZbWNyeG51SFdtQWZxWDIyckxWcFU?oc=5","date":"2025-10-21","type":"pipeline","source":"investorsinhealthcare.com","summary":"Belgium: Insta strengthens presence in PDMP market with acquisition of Prothya Biosolutions - investorsinhealthcare.com","headline":"Belgium: Insta strengthens presence in PDMP market with acquisition of Prothya Biosolutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQT0syYkROQ09kcnlSaEhaMVV4eElKMVplOGRNVElGM20zM25BNFppQzByV3RRRWhzUjYta1BZbWl3TlkyenZQODJxcFM1M0NQTlpKODBXa1ZQYzBJd2oyTldOeVV2QklmOXNCa1JvOUVhdHpZV1dZUnNZY2dlcjBTd1lIZmlzSzNzeC1hNEg5X1NNdlFfNGxDVU94N3hXT2dWeTBicDhLalQyLUN2MlJ1N3NOYkdXYk95aWJtV2VMYkFqWE1yY3I0Uk9GVEliLWNGdllJ?oc=5","date":"2025-10-21","type":"deal","source":"BioPharma APAC","summary":"Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities - BioPharma APAC","headline":"Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNWW1iRHBrWmw3WXdPVkpYYUhjQzJjMDdmYWdadDB5TXFYMEM4aGJXel9ETlFDT3pJNnRFbkE2M3hpRG1SblpLRmVSajEtdWNPTE9QbjJ3QzltZVhFa0dGb3BOSXlaYUFlWW1BMTVHZHVXUjZWTjdmdjRMemUzTmxaNzc0TDhwcnlseU11Vjdraktmb19XQ2kw0gGcAUFVX3lxTFB1Z1FSMjZvTVZpa1c1b3ZSUnl4NEREck0yb2lMVF9iNWJOeVZXYWRDM21DcllEOVVDZ194eFVLM3NkemdaNkUzbmpERi1Vb0ZvdDRRU3NZSTJpV0ZkaS1mRmxYWHQ0WXlKV0YtV1RvWWpHSWdFQWZ6N3FYN2pfRklqTG5TQUxnWXFlQlBONXdyYnM3OThZd0s5QlQ4aQ?oc=5","date":"2025-10-21","type":"deal","source":"Pulse 2.0","summary":"Accord Plasma Buying Prothya Biosolutions To Expand Therapy Capabilities - Pulse 2.0","headline":"Accord Plasma Buying Prothya Biosolutions To Expand Therapy Capabilities - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiREFVX3lxTE92SFZGcmRoVTBubktKblRvV0VhaXlOeHotcklHcmZicDVaZUlyd0hOTTk3czJIVlI3WnhjZ0dLV0dhQTJD?oc=5","date":"2025-10-12","type":"pipeline","source":"964media","summary":"Iraq begins construction of major pharmaceutical hub in southern Baghdad - 964media","headline":"Iraq begins construction of major pharmaceutical hub in southern Baghdad - 964media","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQVFFJX2NKRldYSXJhTUV1cUlWck5jUG1mMHpoY2wxT2RaemNnUDFYNDFCNTdKVUpCWXZUQmc3VDdCSGVya2FaT0Z2RlFPSHBSbFRyRnVlM1hUQkd0ODl6ckN4UDM1bmx2TWxJM250LUhfQnJQdDh0MW14MjNwU0k5ZmkzaHNncWwwdXZheUt0Wkc1eVU?oc=5","date":"2025-08-12","type":"deal","source":"belganewsagency.eu","summary":"Brussels plasma specialist acquired by Indian pharma giant - belganewsagency.eu","headline":"Brussels plasma specialist acquired by Indian pharma giant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNbFdFM3pRZDg5QmhuTU9tVDdGUjBaS0pSNVhFQTJ1NVhITWhlUVBJRUxDMTZiaHdVZk5NR3FGSWxTVkZMdHZtVU9HdUg4a2liSC1CRVVGODNYMmZsZDNfdVpkeDJ4aEdjN2ZNRFhoWVJuQm9UMXRyRzVPUUNkT0Y3N0w3elIxWjRHbUhsRnBPSTV0SDVyR1pMejZ1aVZ1UXg2dXZZMl9iV2dYOG9qektuQXEyN0o0OUIw?oc=5","date":"2025-08-11","type":"deal","source":"PR Newswire","summary":"Intas & Accord signs Agreement to acquire Prothya Biosolutions - PR Newswire","headline":"Intas & Accord signs Agreement to acquire Prothya Biosolutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQN1FadnJpTzRvQkhjdEl4R3dFYkVDSl94dnN1VXJRbFVWaWZweDBuUm12dDQxTVZQT2dHRDBLZ3UtTjJWYzdPbVFCblNUcEIzTkFncGJnVklXQVJQWnc3c1g1aWNiTjktaXo3Rjk0dEI0VldoX2RfMTNXVFpyT3duVGVIVXNOem5uTmFTczdtNUpsMWFMSmJmVG03ZjM1OXlXZFZSdTN3R0YxUWc5RVVUZndPMzBYSUQ3V0JHLXd0Vk5RRWlT?oc=5","date":"2025-08-11","type":"deal","source":"BioSpectrum India","summary":"Intas Pharma signs agreement to acquire Belgium-based Prothya Biosolutions - BioSpectrum India","headline":"Intas Pharma signs agreement to acquire Belgium-based Prothya Biosolutions","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-17","type":"regulatory","source":"Medical Dialogues","summary":"Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Semaglutide Injection for Weight Management - Medical Dialogues","headline":"Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Semaglutide Injection for Weight Management","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}